Urologic Oncologists are expert physicians who focus on diagnosing and treating cancers of the urinary system and male reproductive organs, such as those affecting the kidneys, bladder, prostate, testes, and ureters. These specialists use a combination of advanced surgical techniques, including nephrectomies, cystectomies, and prostatectomies, along with targeted therapies like chemotherapy, radiation, and immunotherapy to treat various forms of urologic cancers. Their extensive knowledge and precision in managing these cancers enable them to develop individualized treatment plans that address each patient's specific condition and health needs.
Urologic oncologists are dedicated to addressing the side effects and complications that can arise from treatment, such as urinary issues, sexual dysfunction, and reproductive health concerns. They work closely with other healthcare professionals, such as medical oncologists and radiation specialists, to provide a comprehensive and integrated approach to care. Urologic oncologists are also at the forefront of clinical research, seeking innovative treatments that can enhance survival rates and reduce long-term complications for patients. Their role goes beyond just treatment—they provide ongoing support, helping patients maintain a high quality of life while navigating the challenges of urologic cancer. Their expertise is invaluable in both improving patient outcomes and offering compassionate, holistic care throughout the cancer journey.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China